טוען...

AAV-mediated local delivery of interferon-β for the treatment of retinoblastoma in preclinical models

Interferon-β (IFN-β has been found to have anti-tumor properties against a variety of malignancies through different mechanisms. However, clinical trials involving systemic administration of IFN-β have been hampered by secondary toxicity and the short half-life of IFN-β in the circulation. In order...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shih, Chie-Schin, Laurie, Nikia, Holzmacher, Jeremy, Hu, Yunyu, Nathwani, Amit C., Davidoff, Andrew M., Dyer, Michael A.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2009
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2725441/
https://ncbi.nlm.nih.gov/pubmed/19306089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12017-009-8059-0
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!